Merry
Well-Known Member
Carol Head, Solve ME/CFS Initiative president, has just announced in an email that the National Institutes of Health has moved ME/CFS research to a new "home" at the National Institute of Neurological Disorders and Stroke (NINDS).
Read about this at the Solve ME/CFS initiative website:
http://solvecfs.org/nih-announces-new-effots-to-advance-mecfs-research?utm_source=getresponse&utm_medium=email&utm_campaign=research_1st&utm_content=Research+1st+News+|+November+|+SPECIAL+EDITION
"The National Institutes of Health announced today that it is taking two major steps to advance research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. NIH has assigned the National Institute of Neurological Disorders and Stroke (NINDS) as the lead of a multi-institute ME/CFS research effort and a re-invigorated Trans-NIH ME/CFS Research Working Group. NIH also is launching a research protocol at the NIH Clinical Center to intensely study individuals with ME/CFS. The move is a landmark one for ME/CFS, which has previously been housed in the Office of Research on Women’s Health and did not receive the attention or funds that a disease with its burden merits."
Read about this at the Solve ME/CFS initiative website:
http://solvecfs.org/nih-announces-new-effots-to-advance-mecfs-research?utm_source=getresponse&utm_medium=email&utm_campaign=research_1st&utm_content=Research+1st+News+|+November+|+SPECIAL+EDITION
"The National Institutes of Health announced today that it is taking two major steps to advance research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. NIH has assigned the National Institute of Neurological Disorders and Stroke (NINDS) as the lead of a multi-institute ME/CFS research effort and a re-invigorated Trans-NIH ME/CFS Research Working Group. NIH also is launching a research protocol at the NIH Clinical Center to intensely study individuals with ME/CFS. The move is a landmark one for ME/CFS, which has previously been housed in the Office of Research on Women’s Health and did not receive the attention or funds that a disease with its burden merits."